The UGT2B17 gene deletion polymorphism and risk of prostate cancer

This publication has 27 references indexed in Scilit:

• Deletion Polymorphism of UDP-Glucuronosyltransferase 2B17 and Risk of Prostate Cancer in African American and Caucasian Men
  Cancer Epidemiology, Biomarkers & Prevention, 2006
• Common deletion polymorphisms in the human genome
  Nature Genetics, 2005
• Characterization of a common deletion polymorphism of the UGT2B17 gene linked to UGT2B15
  Genomics, 2004
• CHARACTERIZATION OF N-GLUCURONIDATION OF THE LUNG CARCINOGEN 4-(METHYLNITROSAMINO)-1-(3-PYRIDYL)-1-BUTANOL (NNAL) IN HUMAN LIVER: IMPORTANCE OF UDP-GLUCURONOSYLTRANSFERASE 1A4
  Drug Metabolism and Disposition, 2004
• A Human Minor Histocompatibility Antigen Resulting from Differential Expression due to a Gene Deletion
  The Journal of Experimental Medicine, 2003
• Hormones and prostate cancer: Current perspectives and future directions
  The Prostate, 2002
• An Allele-Specific Polymerase Chain Reaction Method for the Determination of the D85Y Polymorphism in the Human UDPGlucuronosyltransferase 2B15 Gene in a Case-Control Study of Prostate Cancer
  Annals of Surgical Oncology, 2000
• Glucuronidation: A Dual Control
  General Pharmacology: The Vascular System, 1998
• Chromosomal Localization, Structure, and Regulation of theUGT2B17Gene, Encoding a C19 Steroid Metabolizing Enzyme
  DNA and Cell Biology, 1997
• Isolation and Characterization of a Novel cDNA Encoding a Human UDP-Glucuronosyltransferase Active on C19 Steroids
  Journal of Biological Chemistry, 1996